Building a Compliant GLP-1 Strategy: Where You Can't Take Risks
When it comes to GLP-1 coverage, cost is only the first of three critical questions. The other two, compliance and member adherence, are the ones that decide whether the program drives real value for employees and employers.
This live conversation brings a multi-disciplinary view of GLP-1 compliance and how to de-risk a strategy with three panelists: Sarah Bassler Millar, ERISA Attorney, Anne Fischer, Pharmaceutical Access Expert, and Dr. Nishu Uppal, Internal Medicine MD.
These experts walk through the legal, clinical, and operational decisions employers are making right now on GLP-1 coverage. You will hear the current state of ERISA and ACA requirements, the three coverage models employers are using today, the HRA and cash-pay structures that look compliant but carry real risk, and the clinical case for treating GLP-1s as one part of a broader weight and comorbidity program.
If you are building, reviewing, or defending a GLP-1 strategy, this session is for you.
Direct-to-Employer GLP-1 Coverage
Goodpath’s WeightRx: Total Support program gives employers transparent manufacturer pricing, complete flexibility in cost-share design, and comprehensive clinical care, all in one program. This is a compliant model that enables employers to subsidize GLP-1 costs at rates lower than PBM pricing, even after rebates.